We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. De novo identification of expressed cancer somatic mutations from single-cell RNA sequencing data

    Identifying expressed somatic mutations from single-cell RNA sequencing data de novo is challenging but highly valuable. We propose RESA –...

    Tianyun Zhang, Hanying Jia, ... Ning Shen in Genome Medicine
    Article Open access 18 December 2023
  2. Meta-analysis of 46,000 germline de novo mutations linked to human inherited disease

    Background

    De novo mutations (DNMs) are variants that occur anew in the offspring of noncarrier parents. They are not inherited from either parent...

    Mónica Lopes-Marques, Matthew Mort, ... Luísa Azevedo in Human Genomics
    Article Open access 23 February 2024
  3. Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements

    Background

    We aimed to examine whether patients with de novo and relapsed/progressed stage IIIB–IV non-small cell lung cancer (NSCLC) without...

    Byeong-Chan Oh, Ae-Ryeo Cho, ... Eui-Kyung Lee in BMC Cancer
    Article Open access 29 May 2023
  4. De novo mutations in the BMP signaling pathway in lambdoid craniosynostosis

    Lambdoid craniosynostosis (CS) is a congenital anomaly resulting from premature fusion of the cranial suture between the parietal and occipital...

    Andrew T. Timberlake, Emre Kiziltug, ... Richard P. Lifton in Human Genetics
    Article 23 August 2022
  5. De novo mutations within metabolism networks of amino acid/protein/energy in Chinese autistic children with intellectual disability

    Background

    Autism spectrum disorder (ASD) is often accompanied by intellectual disability (ID). Despite extensive studies, however, the genetic basis...

    Wen-Xiong Chen, Bin Liu, ... Ya-Ping Tang in Human Genomics
    Article Open access 01 November 2022
  6. Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML

    A set of myelodysplasia-related (MDS-R) gene mutations are incorporated into the 2022 European LeukemiaNet risk classification as adverse genetic...

    Xavier Cheng-Hong Tsai, Kuo-Jui Sun, ... Hwei-Fang Tien in Blood Cancer Journal
    Article Open access 04 January 2023
  7. Identification of de novo Mutations in the Chinese Autism Spectrum Disorder Cohort via Whole-Exome Sequencing Unveils Brain Regions Implicated in Autism

    Autism spectrum disorder (ASD) is a highly heritable neurodevelopmental disorder characterized by deficits in social interactions and repetitive...

    Bo Yuan, Mengdi Wang, ... Zilong Qiu in Neuroscience Bulletin
    Article 07 March 2023
  8. Patterns and distribution of de novo mutations in multiplex Middle Eastern families

    While de novo mutations (DNMs) are key to genetic diversity, they are also responsible for a high number of rare disorders. To date, no study has...

    Muhammad Kohailan, Waleed Aamer, ... Khalid A. Fakhro in Journal of Human Genetics
    Article Open access 20 June 2022
  9. Comprehensive de novo mutation discovery with HiFi long-read sequencing

    Background

    Long-read sequencing (LRS) techniques have been very successful in identifying structural variants (SVs). However, the high error rate of...

    Erdi Kucuk, Bart P. G. H. van der Sanden, ... Christian Gilissen in Genome Medicine
    Article Open access 08 May 2023
  10. Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes

    To capture the full spectrum of genetic risk for autism, we performed a two-stage analysis of rare de novo and inherited coding variants in 42,607...

    Xueya Zhou, Pamela Feliciano, ... Wendy K. Chung in Nature Genetics
    Article Open access 18 August 2022
  11. De Novo Sphingolipid Biosynthesis in Atherosclerosis

    Atherosclerosis is the formation of fibrofatty lesions in the arterial wall, and this inflammatory state of the artery is the main cause of advanced...
    Tae-Sik Park, Shivani Devi, ... Kyung-Hee Cho in Sphingolipid Metabolism and Metabolic Disease
    Chapter 2022
  12. Reverse Genetics Systems for the De Novo Rescue of Diverse Members of Paramyxoviridae

    Paramyxoviruses place significant burdens on both human and wildlife health; while some paramyxoviruses are established within human populations,...
    Griffin Haas, Benhur Lee in Reverse Genetics of RNA Viruses
    Protocol 2024
  13. A de novo germline pathogenic BRCA1 variant identified following an osteosarcoma pangenomic molecular analysis

    De novo germline pathogenic variants (gPV) of the BReast CAncer 1 ( BRCA1 ) gene are very rare. Only a few have been described up to date, usually in...

    Adrien Mouren, Albain Chansavang, ... Camille Tlemsani in Familial Cancer
    Article 19 May 2024
  14. A novel de novo canonical splice site mutation in the PTCH1 gene in a male patient with mild psychomotor retardation and autistic traits: a case report

    Basal cell nevus syndrome (BCNS), or Gorlin syndrome, is a rare autosomal dominant disorder caused by mutations in the tumor suppressor gene PTCH1...

    Parisa Mashayekhi, Mir Davood Omrani, ... Ali Dehghanifard in Human Genome Variation
    Article Open access 26 September 2023
  15. Clinical outcomes of advanced non-small cell lung cancer patients harboring distinct subtypes of EGFR mutations and receiving first-line tyrosine kinase inhibitors: brain metastasis and de novo T790M matters

    Background

    The clinical features, survival outcomes and patterns of treatment failure of advanced non-small cell lung cancer (NSCLC) patients...

    Ya Zeng, Tiantian Guo, ... Zhengfei Zhu in BMC Cancer
    Article Open access 21 February 2022
  16. Progressive Ataxia due to de novo Missense Variants in the CACNA1A Gene

    The CACNA1A gene encodes the alpha-1A subunit of P/Q type voltage-gated calcium channel Ca v 2.1, which is associated with a broad clinical spectrum...

    Chen-Hao Zhu, Jin-Yang Yu, ... Zhi-Ying Wu in The Cerebellum
    Article 13 June 2024
  17. Functional dissection of human cardiac enhancers and noncoding de novo variants in congenital heart disease

    Rare coding mutations cause ∼45% of congenital heart disease (CHD). Noncoding mutations that perturb cis -regulatory elements (CREs) likely contribute...

    Feng Xiao, Xiaoran Zhang, ... William T. Pu in Nature Genetics
    Article 20 February 2024
  18. Overlapping pathogenic de novo CNVs in neurodevelopmental disorders and congenital anomalies impacting constraint genes regulating early development

    Neurodevelopmental disorders (NDDs) and congenital anomalies (CAs) are rare disorders with complex etiology. In this study, we investigated the less...

    Seyed Ali Safizadeh Shabestari, Nasna Nassir, ... Mohammed Uddin in Human Genetics
    Article Open access 16 November 2022
  19. A Novel de novo KIF1A Mutation in a Patient with Ataxia, Intellectual Disability and Mild Foot Deformity

    Early-onset ataxias are often difficult to diagnose due to the genetic and phenotypic heterogeneity of patients. Whole exome sequencing (WES) is a...

    Yuka Hama, Hidetoshi Date, ... Yuji Takahashi in The Cerebellum
    Article Open access 13 October 2022
  20. Identification and Functional Analysis of a de novo IKZF3 Mutation in a Pediatric Patient with Combined Immunodeficiency

    AIOLOS, a vital member of the IKAROS protein family, plays a significant role in lymphocyte development and function through DNA binding and...

    Xiaoqi Shi, Xiuli Cao, ... Zuochen Du in Journal of Clinical Immunology
    Article 17 May 2024
Did you find what you were looking for? Share feedback.